KADIAN 200 mg (Morphine Sulfate Extended Release 200 mg)
Pill with imprint KADIAN 200 mg is Brown, Capsule-shape and has been identified as Morphine sulfate extended release 200 mg. It is supplied by Actavis.
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for KADIAN 200 mg
Morphine sulfate extended release
- Imprint:
- KADIAN 200 mg
- Strength:
- 200 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Actavis
- National Drug Code (NDC):
- 00228-3508
More about morphine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 312 Reviews – Add your own review/rating
- Drug class: narcotic analgesics
Consumer resources
- Morphine
- Morphine Long-Acting Tablets
- Morphine Extended-Release Capsules
- Morphine Immediate-Release Tablets and Capsules
- Morphine Injection
- ... +6 more
Other brands: MS Contin, Kadian, Roxanol, Avinza, ... +8 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
